Effectiveness and Safety of Adipose-Derived Regenerative Cells for Treatment of Glaucomatous Neurodegeneration
Clinical trial NCT02144103 · UNKNOWN
Trial details
- NCT number
- NCT02144103
- Sponsor
- Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2018-07-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.